Phillip Bilderback, MD
Surgery · Shelton, WANPI 1386968329
Payments from drug & device makers
Across 58 payments — averaging $201.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- Davol Inc.$368
- Organogenesis Inc.$248
- Medtronic$168
- W. L. Gore & Associates, Inc.$152
- Johnson & Johnson$141
- plus $320 from 8 others
What the payments were for
- Speaking & faculty fees$1251%
- Travel & lodging$2,13818%
- Food & beverage$2,14318%
- Education$7,25062%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 20 | $10,266 |
| Davol Inc. | 4 | $368 |
| Organogenesis Inc. | 6 | $248 |
| Medtronic | 4 | $168 |
| W. L. Gore & Associates, Inc. | 1 | $152 |
| Johnson & Johnson | 3 | $141 |
| Endo Pharmaceuticals Inc. | 12 | $133 |
| KCI USA, Inc. | 2 | $57 |
| Covidien LP | 1 | $45 |
| Convatec Inc. | 1 | $22 |
| Solventum Corporation | 1 | $17 |
| Acceleron Pharma, Inc. | 1 | $17 |
| Kerecis Limited | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$9,315
- DAVINCI XI$750
- PHASIX$341
- GORE ENFORM Biomaterial$152
- Apligraf$125
- Dermagraft$125
- Puraply/Affinity/NuTech$125
- LINX Reflux Management System$120
How this compares
$11,664 in reported general payments places this provider in the 80th percentile of 549 surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 11 | $5,815 |
| Sucralfate | 14 | $1,824 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 12 | $590 |
| Ondansetron Hcl | 13 | $264 |
| Omeprazole | 60 | $239 |
| Famotidine | 14 | $29 |
| Oxycodone Hcl | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other surgery in Shelton
- Martin SchreiberTacoma$2.4M
- Matthew KleinSeattle$328K
- Kevin CliveSilverdale$289K
- Adnan AlseidiSeattle$240K
- Prakash GattaTacoma$212K
- Aileen HwangIssaquah$195K
- Rajeev MisraSilverdale$183K
- Amir BastawrousSeattle$133K
- Alejandro ArnoldCovington$131K
- Brandon VanderwelShoreline$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.